Potent Manufacturing of Solid Oral Dosages Utilizing Dry ...€¦ · • Dry Granulation technique;...
Transcript of Potent Manufacturing of Solid Oral Dosages Utilizing Dry ...€¦ · • Dry Granulation technique;...
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 1
Potent Manufacturing of Solid Oral Dosages Utilizing
Dry Granulation
Shantanu Sonparote
AbbVie Associate Process Development Engineer, AbbVie Manufacturing Science & Technology
March 18, 2014
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 2
• Basics of roller compaction
• Market trends & benefits of Roller Compaction
• Example Process Development
Outline
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 3
• Dry Granulation technique; no liquid is present
• A powder blend is pressed together between rollers to form a ribbon
• Ribbons then pass through a mill, breaking them into granules
• Granulation is necessary to improve the physical characteristics of the blend, such as flow, compressibility, etc.
Basics: What is Roller Compaction?
Mill
Rollers
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 4
Advantages
• Doesn’t involve moisture
• More flexibility with compounds
• Economical: Eliminates drying step
• Technical ease in scalability
• Production Consistency
• Content Uniformity of API
Disadvantages
• Removes some plastic deformation
• Minimal “mixing”
• Very dependent on material properties
Roller Compaction
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 5
Potent compounds tend to have a lower drug loading
Roller Compaction – Role in Potent Manufacturing
Low drug loading allows more control of material properties via excipient selection!
Therefore…
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 6
Material Transfer
Process characterization
Cleaning
Challenges of Potent Roller Compaction
Example Process
Dispensing
Blending
Roller Compaction
Final Blend
Compression
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 8
Isolators must be used to charge neat API into an Intermediate Bin Container (IBC)
This requires additional dispensing time, and more care must be taken to ensure the API is fully transferred
API Dispensing
Container Dock
Split Butterfly Valve
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 9
• Materials remain in the IBC throughout blending process
• To minimize potent exposure the IBC is also used as the vessel to charge the Roller Compactor
• Effective transfer is done through the use of a split-butterfly valve
Blending & Charging
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 10
• The split butterfly valve is open and the roller compaction is started
• Powder material is fed into the roller compactor via tamping and feed augers
• The powder is pressed between two rollers forming ribbons, then milled
• The milled granules are discharged through another split butterfly valve into a receiving IBC
Roller Compaction Startup
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 11
When developing a roller compaction process, it is beneficial to collect samples at two points in the roller compactor:
Roller Compaction Sampling
Ribbon Samples
Granule Samples
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 12
Contained sampling is required; may require unique solutions to be developed/customized based on product requirements
Roller Compaction Sampling
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 13
Testing equipment is contained within an Isolator
• Envelope density provides an understanding of ribbon quality and granule compressibility
• Too low of density results in poor quality ribbons, that may revert back to loose powder
• Too high of density results in higher density granules, which may reduce future compressibility when forming tablets
Ribbon samples can be tested for envelope density
• Particle size data can be used to characterize the material, gauge flowability, and understand the consistency of granulation
Particle size, bulk and tap density on granule samples
Testing gives quantified results that can ensure effective tech transfers
Process Characterization via Testing
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 14
Utilize WIP/CIP Equipment
• WIP/CIP system connects to spray bulbs within the roller compactor chamber
• Surfactants may be used depending on product need
• Cleaning studies are done before work begins; upon completion, equipment is swabbed and tested after washing to ensure no residue remains on the equipment
Mitigates risk of dry powder
when disassembling
equipment
Cleaning
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 15
• Granules can be produced at both pilot scale and commercial scales
• Scale-up is simple: a longer run time will produce more material
• This allows the process to be optimized throughout the development lifecycle and eases transfer into commercial manufacturing
Scalability
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 16
Conclusions
Dry granulation via roller compaction is a suitable method for manufacturing potent drug products
Benefits include:
- Effective at processing APIs at low levels
- Simplicity of scale-up
- Ease of tech transfer
Potent Manufacturing of Solid Oral Dosages Utilizing Dry Granulation | Interphex 2014| Date 4.18.2014 | Copyright © 2014 AbbVie 17
Liam Feely
Jaqueline Wardrop
Michelle Calhoun
Brian C. Anderson
Karen Florjancic
Clark Richards
Patrick Cashman
Acknowledgements